
Sign up to save your podcasts
Or


BMO Capital Markets analyst Evan Seigerman discusses the Trump Administration's deal with Big Pharma. Plus, meet the Suspicious 8, with 6% dividends and lots of problems.
Learn more about your ad choices. Visit megaphone.fm/adchoices
By Barron's4.7
14891,489 ratings
BMO Capital Markets analyst Evan Seigerman discusses the Trump Administration's deal with Big Pharma. Plus, meet the Suspicious 8, with 6% dividends and lots of problems.
Learn more about your ad choices. Visit megaphone.fm/adchoices

3,221 Listeners

1,720 Listeners

522 Listeners

973 Listeners

2,168 Listeners

295 Listeners

1,041 Listeners

349 Listeners

378 Listeners

212 Listeners

908 Listeners

1,307 Listeners

109 Listeners

208 Listeners

65 Listeners

74 Listeners

144 Listeners

21 Listeners